Pancreatitis or Pancreatic Cancer with DPP-4 Inhibitors

被引：0
|
作者：
不详
机构：
来源：
PHARMACEUTICAL MEDICINE | 2019年 / 33卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：540 / 540
页数：1
相关论文
共 50 条
  • [1] Pancreatitis or pancreatic cancer with DPP-4 inhibitors
    Reactions Weekly, 2019, 1770 (1) : 9 - 9
  • [2] DPP-4 inhibitors
    Ahren, Bo
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 21 (04) : 517 - 533
  • [3] Role of SGLT2 Inhibitors, DPP-4 Inhibitors, and Metformin in Pancreatic Cancer Prevention
    Laeeq, Tooba
    Ahmed, Maheen
    Sattar, Hina
    Zeeshan, Muhammad Hamayl
    Ali, Meher Binte
    CANCERS, 2024, 16 (07)
  • [4] DPP-4 inhibitors in diabetic complications: role of DPP-4 beyond glucose control
    Eun Ju Bae
    Archives of Pharmacal Research, 2016, 39 : 1114 - 1128
  • [5] DPP-4 Inhibitors and the Occurrence of Infections
    Willemen, M. J. C.
    Mantel-Teeuwisse, A. K.
    Straus, S. M. J. M.
    Egberts, A. C. G.
    Leufkens, H. G. M.
    DRUG SAFETY, 2010, 33 (10) : 937 - 937
  • [6] DPP-4 inhibitors and atherosclerosis: The promise
    Jialal, Ishwarlal
    Bajaj, Mandeep
    ATHEROSCLEROSIS, 2013, 227 (02) : 224 - 225
  • [7] Bullous pemphigoid with DPP-4 inhibitors
    Reactions Weekly, 2019, 1745 (1) : 1 - 1
  • [8] Pharmacoeconomic analysis of DPP-4 inhibitors
    Teramachi, H.
    Ohta, H.
    Tachi, T.
    Toyoshima, M.
    Mizui, T.
    Goto, C.
    Tsuchiya, T.
    PHARMAZIE, 2013, 68 (11): : 909 - 915
  • [9] Renoprotective Effects of DPP-4 Inhibitors
    Kawanami, Daiji
    Takashi, Yuichi
    Takahashi, Hiroyuki
    Motonaga, Ryoko
    Tanabe, Makito
    ANTIOXIDANTS, 2021, 10 (02) : 1 - 17
  • [10] DPP-4 inhibitors: focus on safety
    Tella, Sri Harsha
    Rendell, Marc S.
    EXPERT OPINION ON DRUG SAFETY, 2015, 14 (01) : 127 - 140
12345